Pfizer’s Viagra Case Withers In China

Law360, New York (February 5, 2007, 12:00 AM EST) -- Pfizer Inc. has suffered a blow in its bid to protect the rights to Viagra in China, with a Beijing court ruling that the drug maker can no longer use the name Wei Ge, or “mighty brother,” to market the erectile dysfunction drug because a Chinese pharmaceutical company has already registered the brand.

The Beijing No. 1 Intermediate People's Court said Guangzhou Welman, a Chinese anti-impotency drug maker, should be allowed to keep the rights to the brand name Wei Ge because it registered the name...
To view the full article, register now.